Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial. (Q51910874)
Jump to navigation
Jump to search
scientific article published in July 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial. |
scientific article published in July 2007 |
Statements
1 reference
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial. (English)
1 reference
Bonaventura Clotet
1 reference
Christine Katlama
1 reference
Thomas Campbell
1 reference
Margaret Johnson
1 reference
Arend Moll
1 reference
William Towner
1 reference
Benoit Trottier
1 reference
Monika Peeters
1 reference
Johan Vingerhoets
1 reference
Goedele de Smedt
1 reference
Benny Baeten
1 reference
Greet Beets
1 reference
Rekha Sinha
1 reference
Brian Woodfall
1 reference
DUET-2 study group
1 reference
1 July 2007
1 reference
1 reference
370
1 reference
9581
1 reference
39-48
1 reference
Identifiers
1 reference